Lilly direct-selling Zepbound at $499/mo — compare with 11 other programs

Mounjaro vs Retatrutide

Editorial comparison of Mounjaro (tirzepatide) and Retatrutide (retatrutide). Same drug class context, trial-anchored data, no marketing claims.

Reviewed by the glpzoom Editorial Team against primary clinical sources — FDA labeling, peer-reviewed trials, and specialty-society guidelines.
Content current as of June 2026; updated when guidance or availability changes.

Side-by-side

DimensionMounjaroRetatrutide
Generic nametirzepatideretatrutide
ManufacturerEli LillyEli Lilly
FDA approved2022
MechanismSame as Zepbound — dual GLP-1/GIP receptor agonist. Strong glycemic effect plus weight loss.Where semaglutide hits one receptor and tirzepatide two, retatrutide adds a third: the glucagon receptor.
DosingTitrated 2.5mg → 15mg weekly over months, same schedule as Zepbound.Investigational. Trial dosing is once-weekly subcutaneous injection with gradual titration; final approved doses are not set.
CostSimilar to Zepbound — list ~$1,000/month, LillyDirect Self-Pay $399-549/month.No commercial price exists. Available only via clinical-trial enrollment. Beware any website selling 'retatrutide' today, it is not a legal product.
Pivotal trial result2.0–2.3% HbA1c reduction across SURPASS trials (15 mg dose)~24% mean body-weight reduction at 48 weeks (highest dose, Phase 2)

Full Mounjaro review →

FDA-approved tirzepatide for type 2 diabetes. Off-label for weight loss is common.

Full Retatrutide review →

Investigational triple agonist (GLP-1 / GIP / glucagon). Phase 3 weight loss approached ~24%, the highest yet. Not FDA-approved; expected 2027.

Frequently asked

Is Mounjaro or Retatrutide more effective?+

In their pivotal trials, Mounjaro reported 2.0–2.3% HbA1c reduction across SURPASS trials (15 mg dose), while Retatrutide reported ~24% mean body-weight reduction at 48 weeks (highest dose, Phase 2). Head-to-head results vary by patient profile, dose tolerated, and adherence — these trial numbers describe averages, not what every individual experiences.

How do Mounjaro and Retatrutide compare on cost?+

Mounjaro: Similar to Zepbound — list ~$1,000/month, LillyDirect Self-Pay $399-549/month. Retatrutide: No commercial price exists. Available only via clinical-trial enrollment. Beware any website selling 'retatrutide' today, it is not a legal product. Real out-of-pocket depends on insurance formulary tier, manufacturer savings programs, and whether a direct-pay channel is available.

Can I switch from Mounjaro to Retatrutide?+

Switching between brand-name treatments in the same drug class is common, but the conversion is not always 1:1. Discuss the switch with your prescriber — they'll usually re-titrate dosing rather than substitute equivalent strengths directly.

Are Mounjaro and Retatrutide the same drug?+

No. Mounjaro (tirzepatide) and Retatrutide (retatrutide) are distinct medications from Eli Lilly and Eli Lilly respectively. They may share a drug class or mechanism but differ in active ingredient, dosing, and approved use.

We may earn a commission when you click links to partners. Affiliate disclosure.